Report by Abacus Research
Under its new CEO, CHRW has implemented a lean, AI-enabled operating model that has enabled the company to grow earnings despite struggling topline growth. Abacus expects EPS to average ~19% CAGR over the next 3 years, even without any help from a cyclical recovery, highlighting exceptional operating leverage and incremental margins of ~100%. Importantly, the demand environment is unlikely to worsen without a severe recession, hence any cyclical upside is mostly a free option. If investors gain confidence that high incremental margins are sustainable and CHRW is once again a structural share gainer, Abacus believes the stock can continue to re-rate higher.